Expertise in
8
conditions

Dr. Otto Dueno

Psychiatry
Office
2621 Dryden Rd Ste 100, 
Moraine, OH 
Offers Telehealth
Expertise in
8
conditions
Office
2621 Dryden Rd Ste 100, 
Moraine, OH 

Overview

Otto Dueno is a Psychiatrist practicing medicine in Moraine, Ohio.

Dr. Dueno is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Major Depression, Bipolar Disorder (BPD), Seasonal Affective Disorder (SAD), and Generalized Anxiety Disorder (GAD).

He is actively involved in clinical research, participating in 10 clinical trials.

Specialties

Psychiatry

Licenses

Psychiatry & Neurology in OH

Hospital Affiliations

Kettering Health Miamisburg

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Buckeye Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Health
  • HMO
  • PPO
Medical Mutual
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
Simply Healthcare
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 17 Less Insurance Carriers -

Locations

Office
2621 Dryden Rd Ste 100, Moraine, OH 45439
Other Locations
Midwest Clinical Research Center LLC
1 Elizabeth Pl Ste G3, Dayton, OH 45417

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

A Phase 2a, Randomized, Double-blind, Placebo-controlled Proof of Concept Study to Evaluate the Effects of Oral BTRX-335140 (NMRA-335140) Versus Placebo in Subjects With Major Depressive Disorder
A Phase 2a, Randomized, Double-blind, Placebo-controlled Proof of Concept Study to Evaluate the Effects of Oral BTRX-335140 (NMRA-335140) Versus Placebo in Subjects With Major Depressive Disorder
Enrollment Status: Completed
Publish Date: May 29, 2025
Intervention Type: Drug
Study Drug: BTRX-335140
Study Phase: Phase 2
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 in Treatment-Seeking Individuals With Methamphetamine Use Disorder
A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety and Efficacy of IXT-m200 in Treatment-Seeking Individuals With Methamphetamine Use Disorder
Enrollment Status: Terminated
Publish Date: October 04, 2024
Intervention Type: Drug, Other
Study Phase: Phase 2
Phase 2a Multicenter Randomized Double-Blind Placebo-Controlled Study to Assess the Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing of REL-1017 as Adjunctive Therapy in the Treatment of Pts Diagnosed With MDD
Phase 2a Multicenter Randomized Double-Blind Placebo-Controlled Study to Assess the Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing of REL-1017 as Adjunctive Therapy in the Treatment of Pts Diagnosed With MDD
Enrollment Status: Completed
Publish Date: November 01, 2023
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of CX-8998 for Essential Tremor
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of CX-8998 for Essential Tremor
Enrollment Status: Completed
Publish Date: November 23, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
A Phase IIIb Multi-Center, Open-Label, Mirror-Image, Trial in Adult Subjects With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
Enrollment Status: Terminated
Publish Date: September 05, 2021
Intervention Type: Combination product
Study Drug: ABILIFY MYCITE
Study Phase: Phase 3
A Multicenter, Dose-Optimized, Open-Label Safety Study With KP415 in Children With Attention-Deficit/Hyperactivity Disorder
A Multicenter, Dose-Optimized, Open-Label Safety Study With KP415 in Children With Attention-Deficit/Hyperactivity Disorder
Enrollment Status: Completed
Publish Date: July 19, 2021
Intervention Type: Drug
Study Phase: Phase 3
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
An 8-Week Prospective Randomized, Controlled, Double-Blind Trial of the Genecept Assay ™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With Major Depressive Disorder (MDD)
Enrollment Status: Completed
Publish Date: August 28, 2020
Intervention Type: Genetic, Other
Study Phase: Not Applicable
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant Depression
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant Depression
Enrollment Status: Completed
Publish Date: July 09, 2019
Intervention Type: Drug
Study Phase: Phase 1
CSD170304: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Electronic and Combustible Cigarettes
CSD170304: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Electronic and Combustible Cigarettes
Enrollment Status: Completed
Publish Date: November 14, 2017
Intervention Type: Other
Study Phase: Not Applicable
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
A Phase 2, Double-Blind, Placebo-Controlled Study of NSI-189, a Neurogenic Compound Among Out-Patients With Major Depressive Disorder
Enrollment Status: Unknown
Publish Date: February 24, 2017
Intervention Type: Drug
Study Drug: NSI-189
Study Phase: Phase 2
View 9 Less Clinical Trials
Similar Doctors
Expertise in
10
conditions
Dr. Amita Patel
Psychiatry
Expertise in
10
conditions
Dr. Amita Patel
Psychiatry

AMITA R. Patel M.D. Inc.

627 S Edwin C Moses Blvd Ste K, 
Dayton, OH 
 (26.8 miles away)
937-424-1000
Languages Spoken:
English
See accepted insurances

Amita Patel is a Psychiatrist practicing medicine in Dayton, Ohio. Dr. Patel is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Alzheimer's Disease, Seasonal Affective Disorder (SAD), Major Depression, Vascular Dementia, and Gastrostomy.

Expertise in
5
conditions
Dr. Susan Mcelroy
Psychiatry
Expertise in
5
conditions
Dr. Susan Mcelroy
Psychiatry

Office

4075 Old Western Row Rd # C, 
Mason, OH 
 (14.6 miles away)
513-536-4673
Languages Spoken:
English
See accepted insurances

Susan Mcelroy is a Psychiatrist practicing medicine in Mason, Ohio. Dr. Mcelroy is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Bipolar Disorder (BPD), Bulimia, Anorexia, and Major Depression.

Expertise in
12
conditions
Dr. James Shackson
Psychiatry
Expertise in
12
conditions
Dr. James Shackson
Psychiatry

Brookwood Retirement Community

12100 Reed Hartman Hwy, 
Cincinnati, OH 
 (13.8 miles away)
513-382-5112
Languages Spoken:
English
See accepted insurances

James Shackson is a Psychiatrist practicing medicine in Cincinnati, Ohio. Dr. Shackson is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Seasonal Affective Disorder (SAD), Major Depression, Generalized Anxiety Disorder (GAD), and Schizophrenia.

Frequently Asked Questions about Dr. Otto Dueno

How do I make an appointment with Dr. Otto Dueno?

You can book an appointment with Dr. Otto Dueno by calling their office at 937-281-0900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Otto Dueno a top-rated expert for Major Depression?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Otto Dueno is classified as an Distinguished expert for Major Depression, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Otto Dueno specialize in?

While Dr. Otto Dueno is a Psychiatry, they have specific expertise in Major Depression, Bipolar Disorder (BPD), and Seasonal Affective Disorder (SAD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Psychiatry.

Does Dr. Otto Dueno accept my insurance?

Dr. Otto Dueno accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 937-281-0900 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dueno's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile